These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20820820)

  • 1. A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan.
    Kusakabe A; Tanaka Y; Inoue M; Kurbanov F; Tatematsu K; Nojiri S; Joh T; Tsugane S; Mizokami M
    J Gastroenterol; 2011 Jan; 46(1):117-24. PubMed ID: 20820820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
    Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
    Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
    Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
    World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors analysis and a new risk scoring system predicting hepatocarcinogenesis for chronic genotype C HBV infected patients].
    Liu JL; Pu R; Ma LT; Wang S; Yin JH; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1459-1464. PubMed ID: 30462954
    [No Abstract]   [Full Text] [Related]  

  • 11. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
    Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
    Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection.
    Lee JH; Han KH; Lee JM; Park JH; Kim HS
    Clin Vaccine Immunol; 2011 Jun; 18(6):914-21. PubMed ID: 21490166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
    Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
    Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
    Iloeje UH; Yang HI; Chen CJ
    Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
    Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
    Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.
    Fang ZL; Sabin CA; Dong BQ; Ge LY; Wei SC; Chen QY; Fang KX; Yang JY; Wang XY; Harrison TJ
    Am J Gastroenterol; 2008 Sep; 103(9):2254-62. PubMed ID: 18844615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Kim GA; Han S; Choi GH; Choi J; Lim YS
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mother-to-child transmission of hepatitis B virus: evolution of hepatocellular carcinoma-related viral mutations in the post-immunization era.
    Li Z; Xie Z; Ni H; Zhang Q; Lu W; Yin J; Liu W; Ding Y; Zhao Y; Zhu Y; Pu R; Zhang H; Dong H; Fu Y; Sun Q; Xu G; Cao G
    J Clin Virol; 2014 Sep; 61(1):47-54. PubMed ID: 24973814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.